Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9277173 | Enfermedades Infecciosas y Microbiología Clínica | 2005 | 6 Pages |
Abstract
Once the microorganism responsible for VAP has been isolated, antibiotic therapy can be adapted, based on deescalation, to reduce the emergence of resistant bacteria. Recent studies suggest that shorter antibiotic regimens reduce the emergence of antibiotic-resistant pathogens, cost and adverse events.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Loreto Vidaur, Miriam Ochoa, Emilio DÃaz, Jordi Rello,